Bestell- und Beratungshotline
Tel.: +49 (0)221 788 748-11
E-Mail: service[at]marktforschung.de

Tools
Werbung:
Marktanalyse - Cough, Cold and Allergy (Hay Fever) Remedies in Belgium
Euromonitor
6 / 2012
42 Seiten
| Typ: | Marktanalyse |
| Sprache: | Englisch |
| Regionen: | Belgien |
| Verfügbarkeit: | verfügbar |
Bitte wählen Sie ein Lieferformat und klicken Sie unten auf einen Bestellbutton:
In 2011 cough, cold and allergy (hay fever) remedies’ volume sales suffered as a result of 'unfavourable” weather — after the cold autumn of 2010, the winter and autumn seasons in 2011 were very mild, and the number of outbreaks of infectious diseases was lower than is typical. Also, many years after the questioning of combination cough, cold and allergy remedies — as a result of which most were withdrawn — the category was again questioned by the Commission des Médicaments, particularly...
Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN BELGIUM
Euromonitor International
June 2012
LIST OF CONTENTS AND TABLES
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
Table 3 Sales of Decongestants by Category: Value 2006-2011
Table 4 Sales of Decongestants by Category: % Value Growth 2006-2011
Table 5 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
Table 6 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
Table 7 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2007-2011
Table 8 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2008-2011
Table 9 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
Table 10 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016
Laboratoria Qualiphar NV SA in Consumer Health (belgium)
Strategic Direction
Key Facts
Summary 1 Qualiphar NV SA, Laboratoria: Key Facts
Summary 2 Qualiphar NV SA, Laboratoria: Operational Indicators
Company Background and Production
Competitive Positioning
Summary 3 Qualiphar NV SA, Laboratoria: Competitive Position 2011
Tilman NV SA in Consumer Health (belgium)
Strategic Direction
Key Facts
Summary 4 Tilman NV SA: Key Facts
Summary 5 Tilman NV SA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 6 Tilman NV SA: Competitive Position 2011
Executive Summary
Slight But Fragile Recovery in 2011
Negative Environment for Consumer Health Affects Sales
Disparate Results in A Still Fragmented Competitive Environment
Distribution Remains Under the Control of Pharmacies Despite Some Changes
Bleak Prospects Overall
Key Trends and Developments
Fragile Economic Recovery To Result in A Temporary Improvement
Authorities and Medical Experts Blow Hot and Cold
More Health & Wellness, Certainly, But Also More Realism
Remedies for Increasingly Stressful Lifestyles
Brand Equity To Remain the Key in A Restricted Environment
Market Indicators
Table 11 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 12 Life Expectancy at Birth 2006-2011
Market Data
Table 13 Sales of Consumer Health by Category: Value 2006-2011
Table 14 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 15 Consumer Health Company Shares 2007-2011
Table 16 Consumer Health Brand Shares 2008-2011
Table 17 Penetration of Private Label by Category 2006-2011
Table 18 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 19 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 20 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 21 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements - Registration and Classification
Switch Climate
Self-medication and Preventative Medicine
Generics
Switches
Summary 7 OTC - Switches 2009-2011
Sources
Summary 8 Research Sources
Euromonitor International
June 2012
LIST OF CONTENTS AND TABLES
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
Table 3 Sales of Decongestants by Category: Value 2006-2011
Table 4 Sales of Decongestants by Category: % Value Growth 2006-2011
Table 5 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
Table 6 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
Table 7 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2007-2011
Table 8 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2008-2011
Table 9 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
Table 10 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016
Laboratoria Qualiphar NV SA in Consumer Health (belgium)
Strategic Direction
Key Facts
Summary 1 Qualiphar NV SA, Laboratoria: Key Facts
Summary 2 Qualiphar NV SA, Laboratoria: Operational Indicators
Company Background and Production
Competitive Positioning
Summary 3 Qualiphar NV SA, Laboratoria: Competitive Position 2011
Tilman NV SA in Consumer Health (belgium)
Strategic Direction
Key Facts
Summary 4 Tilman NV SA: Key Facts
Summary 5 Tilman NV SA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 6 Tilman NV SA: Competitive Position 2011
Executive Summary
Slight But Fragile Recovery in 2011
Negative Environment for Consumer Health Affects Sales
Disparate Results in A Still Fragmented Competitive Environment
Distribution Remains Under the Control of Pharmacies Despite Some Changes
Bleak Prospects Overall
Key Trends and Developments
Fragile Economic Recovery To Result in A Temporary Improvement
Authorities and Medical Experts Blow Hot and Cold
More Health & Wellness, Certainly, But Also More Realism
Remedies for Increasingly Stressful Lifestyles
Brand Equity To Remain the Key in A Restricted Environment
Market Indicators
Table 11 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 12 Life Expectancy at Birth 2006-2011
Market Data
Table 13 Sales of Consumer Health by Category: Value 2006-2011
Table 14 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 15 Consumer Health Company Shares 2007-2011
Table 16 Consumer Health Brand Shares 2008-2011
Table 17 Penetration of Private Label by Category 2006-2011
Table 18 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 19 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 20 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 21 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements - Registration and Classification
Switch Climate
Self-medication and Preventative Medicine
Generics
Switches
Summary 7 OTC - Switches 2009-2011
Sources
Summary 8 Research Sources
- Cough, Cold and Allergy (Hay Fever) Remedies in Australia
- Cough, Cold and Allergy (Hay Fever) Remedies in Croatia
- Cough, Cold and Allergy (Hay Fever) Remedies in Egypt
- Cough, Cold and Allergy (Hay Fever) Remedies in Romania
- Cough, Cold and Allergy (Hay Fever) Remedies in Saudi Arabia
- Cough, Cold and Allergy (Hay Fever) Remedies in Croatia
- Cough, Cold and Allergy (Hay Fever) Remedies in Slovenia
- Cough, Cold and Allergy (Hay Fever) Remedies in Kenya
- Cough, Cold and Allergy (Hay Fever) Remedies in Pakistan
- Cough, Cold and Allergy (Hay Fever) Remedies in Portugal
- Allergies – Pipeline Review, H2 2012
- Cough, Cold and Allergy (Hay Fever) Remedies in Iran
- Cough, Cold and Allergy (Hay Fever) Remedies in South Korea
- Cough, Cold and Allergy (Hay Fever) Remedies in the Netherlands
- Cough, Cold and Allergy (Hay Fever) Remedies in Uzbekistan
- Cough, Cold and Allergy (Hay Fever) Remedies in Vietnam
- Peanut Allergy – Pipeline Review, H2 2012
- Pollen Allergy – Pipeline Review, H2 2012
- Cough, Cold and Allergy (Hay Fever) Remedies in Algeria
- Cough, Cold and Allergy (Hay Fever) Remedies in Austria
*Alle Preise sind netto ausgewiesen. In Abhängigkeit von Ihrer Rechnungsanschrift ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Unser Angebot richtet sich ausschließlich an Unternehmen, Gewerbetreibende und Freiberufler.
Für Sie protokollierte Studien / Marktanalysen:
zuletzt angesehene Studien:

